|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Pharmacia |
| Information provided by: | NIH AIDS Clinical Trials Information Service |
| ClinicalTrials.gov Identifier: | NCT00001995 |
Purpose
To determine if a drug regimen containing rifabutin will eradicate or decrease the numbers of Mycobacterium avium complex (MAC) organisms in blood, improve the symptoms associated with MAC infection, and increase survival in patients with AIDS. To assess the safety of the drug regimen.
| Condition | Intervention |
|
Mycobacterium Avium-Intracellulare Infection HIV Infections |
Drug: Rifabutin |
| MedlinePlus related topics: | AIDS |
| Drug Information available for: | Rifabutin |
| Study Type: | Interventional |
| Study Design: | Treatment, Double-Blind, Safety Study |
| Official Title: | A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria
Concurrent Medication:
Allowed:
Patients must have the following:
Prior Medication:
Allowed:
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
Concurrent Medication:
Excluded:
Patients with the following are excluded:
Prior Medication:
Excluded within 4 weeks:
Contacts and Locations| United States, Arizona | |||||
| Maricopa County Med Ctr | |||||
| Phoenix, Arizona, United States, 85010 | |||||
| United States, California | |||||
| San Francisco Veterans Administration Med Ctr | |||||
| San Francisco, California, United States, 94121 | |||||
| Ctr for Special Immunology | |||||
| Irvine, California, United States, 92718 | |||||
| AIDS Community Research Consortium | |||||
| Redwood City, California, United States, 94063 | |||||
| Southwest Community Based AIDS Treatment Group - COMBAT | |||||
| Los Angeles, California, United States, 90028 | |||||
| HIV Research Group | |||||
| San Diego, California, United States, 92102 | |||||
| Bay Harbor Hosp | |||||
| Harbor City, California, United States, 90710 | |||||
| Davies Med Ctr | |||||
| San Francisco, California, United States, 94114 | |||||
| United States, District of Columbia | |||||
| Veterans Administration Med Ctr | |||||
| Washington, District of Columbia, United States, 20422 | |||||
| United States, Florida | |||||
| Miami Veterans Administration Med Ctr | |||||
| Miami, Florida, United States, 33125 | |||||
| Mem Hosp Hollywood | |||||
| Hollywood, Florida, United States, 33021 | |||||
| Ctr for Special Immunology | |||||
| Fort Lauderdale, Florida, United States, 33316 | |||||
| TheraFirst Med Ctrs Inc | |||||
| Fort Lauderdale, Florida, United States, 33308 | |||||
| United States, Georgia | |||||
| Infectious Disease Research Consortium of Georgia | |||||
| Atlanta, Georgia, United States, 30076 | |||||
| United States, Minnesota | |||||
| Dr Frank Rhame | |||||
| Minneapolis, Minnesota, United States, 55455 | |||||
| United States, Missouri | |||||
| Research Med Ctr | |||||
| Kansas City, Missouri, United States, 64132 | |||||
| United States, New Jersey | |||||
| North Jersey Community Research Initiative | |||||
| Newark, New Jersey, United States, 071032842 | |||||
| United States, New York | |||||
| Chelsea Village Med Ctr / Saint Vincent's Hosp | |||||
| New York, New York, United States, 10014 | |||||
| Nassau County Med Ctr | |||||
| East Meadow, New York, United States, 11554 | |||||
| United States, South Carolina | |||||
| Dr Alfred F Burnside Jr | |||||
| Columbia, South Carolina, United States, 29204 | |||||
| United States, Virginia | |||||
| Infectious Disease Physicians Inc | |||||
| Annandale, Virginia, United States, 22203 | |||||
| United States, Wisconsin | |||||
| Milwaukee County Med Complex | |||||
| Milwaukee, Wisconsin, United States, 53226 | |||||
| Pharmacia |
More Information
|
Dautzenberg B, Castellani P, Truffot-Pernot CH, Leng B, Sassella D. Bacteriological assessment of rifabutin versus placebo for M. avium bacteremia in AIDS patients. Int Conf AIDS. 1996 Jul 7-12;11(1):117 (abstract no MoB1359)
  |
| Study ID Numbers: | 048C, CS 087065 |
| First Received: | November 2, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00001995 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|